- Home
- Software
- switzerland
- patient data
Show results for
Refine by
Patient Data Software In Switzerland
8 software items found
Manufactured by:ABCDx based inGeneva, SWITZERLAND
ABCDx detains the know-how and can provide the algorithm in a software for smartphone of tablet. The App that takes in all the available patient information and reports the assessment based on an ABCDx-owned ...
Manufactured by:NDD Medical Technologies based inAndover, MASSACHUSETTS (USA)
All products include EasyOne Connect, the integrated software platform that works on a standalone or server database for all NDD devices and provides advanced PFT software functionality, including customized provocation protocols, QC grading, result interpretation, and external PFT import. Get maximum efficiency in installation, data management, and EMR integration by standardizing on our ...
by:BC Platforms based inZürich, SWITZERLAND
BC | INSIGHT is a data and research management solution for clinical genomics studies. Genomic and phenotypic data is collected and stored on the platform, and users have access to data and tools through an application account. All common data types for NGS, GWAS, variant analysis, linkage, and other statistics can be managed on the platform. BC|INSIGHT scales up from small candidate gene studies ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop inherited cancer depends on the ability to characterize genes ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer.1 Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Accurate identification and reporting of Homologous Recombination Deficiency (HRD) status are critical for better patient management. SOPHiA DDM Dx HRD Solution is a CE-marked in vitro diagnostic (IVD) application leveraging low-pass Whole Genome Sequencing (WGS) and a proprietary deep-learning algorithm. Powered by the advanced analytical capabilities of SOPHiA DDM™ ...
by:BrightInsight, Inc based inSan Jose, CALIFORNIA (USA)
The leading global regulated Digital Health platform for biopharma and ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of ...